ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MOBI vs TMCI // ALTMAN Z-SCORE & DEBT/EQUITY

Mobia Medical Inc. (NASDAQ) VS. Treace Medical Concepts Inc. (NASDAQ) • 15-METRIC TALLY: MOBI 1 — TMCI 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MOBI VS. TMCI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MOBI TMCI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 79.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -32.40% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -8.96% — TIE /fcf-yield <GO>
Operating Margin — -25.50% — TIE /operating-margins <GO>
Net Profit Margin — -27.70% — TIE /net-margins <GO>
Revenue Growth (YoY) — 1.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 0.90 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 4/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.3 62.7 -1.40 TMCI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $375.2M $329.1M $46.1M MOBI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MOBI REV TMCI REV MOBI GROSS % TMCI GROSS % MOBI FCF TMCI FCF
FY 2025 $0 $212.7M — 79.8% — -$29.5M
FY 2024 — $209.4M — 80.4% — -$48.8M
FY 2023 — $187.1M — — — -$34.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MOBI // BETA —
TMCI // BETA —